Canopy Growth Corporation (CGC) concluded trading on Tuesday at a closing price of $2.74, with 4.57 million shares of worth about $12.53 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -56.23% during that period and on December 31, 2024 the price remained unchanged. Currently the company’s common shares owned by public are about 98.67M shares, out of which, 97.94M shares are available for trading.
Stock saw a price change of -4.53% in past 5 days and over the past one month there was a price change of -29.20%. Year-to-date (YTD), CGC shares are showing a performance of -46.38% which decreased to -46.38% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.65 but also hit the highest price of $14.92 during that period. The average intraday trading volume for Canopy Growth Corporation shares is 5.85 million. The stock is currently trading -11.97% below its 20-day simple moving average (SMA20), while that difference is down -29.56% for SMA50 and it goes to -55.78% lower than SMA200.
Canopy Growth Corporation (NASDAQ: CGC) currently have 98.67M outstanding shares and institutions hold larger chunk of about 9.52% of that.
The stock has a current market capitalization of $270.36M and its 3Y-monthly beta is at 0.87. It has posted earnings per share of -$4.94 in the same period. It has Quick Ratio of 1.07 while making debt-to-equity ratio of 1.20. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CGC, volatility over the week remained 5.69% while standing at 6.30% over the month.
Stock’s fiscal year EPS is expected to rise by 60.79% while it is estimated to increase by 74.90% in next year. EPS is likely to grow at an annualized rate of 35.49% for next 5-years, compared to annual growth of 20.88% made by the stock over the past 5-years.
Coverage by Bernstein stated Canopy Growth Corporation (CGC) stock as an Underperform in their note to investors on November 02, 2022, suggesting a price target of $1.50 for the stock. Stock get an Underweight rating from Barclays on March 22, 2022.
